Chambers & Partners has detected the use of an ad blocker.
We make use of tailor-made ads to enhance your experience of our website.
Please 'whitelist' http://www.chambersandpartners.com.
Close
Europe Guide

Life Sciences — Netherlands

Band 1

第一等

From the Chambers Europe guide

Basic facts about the department
- Heads of department: Hein van den Bos and Bert Oostling
- 5 partners
- 10 other qualified lawyers

What the team is known for Strong life science practice with excellent regulatory capabilities. Handles a broad range of Dutch and EU regulatory issues, compliance and litigation related to the sector. Praised for its strong reputation at the international level and regularly involved on cross-border regulatory matters. Fully integrated with the firm's well-regarded IP and patent team, which complements the offering to clients with advice on pharmaceutical patents.

Strengths Sources praise the firm's "truly international coverage of the life sciences area."

Work highlights Continued to advise Biomet on patient product-liability claims in various European jurisdictions related to hip prosthetics.

Significant clients Merck, Astellas, BMS, Biogen, Lilly.

Notable practitioners  

Hein van den Bos is praised by clients for his "really helpful and understanding approach to internal issues." He leads the regulatory angle of the practice and advises on a range of compliance issues including rules governing the advertising of pharmaceutical products, exclusivity rights for new treatments and pricing negotiations relating to medicinal products.

^ Return to Top

Band 1

第一等

From the Chambers Europe guide

Basic facts about the department
- Heads of Department: Carla Schoonderbeek and Simon Dack
- 6 partners
- 5 other qualified lawyers

What the team is known for A market-leading firm for life sciences in the Netherlands which also has exceptional reputation at an EU-wide level. Combines closely with the firm's highly reputed IP and patent practice to cover a wide spectrum of issues faced in the life sciences sector. Clients include leading global pharmaceutical and biological companies, covering regulatory matters such as market authorisation, clinical trials, product distribution and compliance, as well as exhibiting strength in medical devices and litigation.

Strengths Clients profess that the firm is "top quality" and its lawyers are "very bright, grasped facts quickly and delivered an excellent result for us. They also have a well rounded team that includes an in-house patent attorney."

Work highlights Represented Novartis in the European General Court in relation to issues surrounding the grant of a derogation from the company's orphan market exclusivity rights. 

Notable practitioners  

Carla Schoonderbeek leads the regulatory practice at the firm and is widely reputed as a leading expert in the life sciences regulatory arena throughout Europe. Sources confirm that "there is little doubt she is one of the best in the regulatory field," with another describing her a "a phenomenon." Acting at both the domestic and EU levels, she frequently represents innovators in the pharma and biotech fields on a diverse range of product and trial issues, compliance and enforcement litigation.

^ Return to Top

Band 2

第二等

From the Chambers Europe guide

Basic facts about the department
- Heads of department: Carine van den Brink and Erik Vollebregt
- 2 partners
- 3 other qualified lawyers

What the team is known for Widely respected life sciences boutique, praised for its technical knowledge and experience in regulatory aspects of the pharmaceutical, medical and biotech industries. Well known for its contribution to internationally interesting deals and its work relating to medical devices. Also handles regulatory issues relating to M&A and joint ventures as well as disputes between pharmaceutical developers.

Strengths Clients rate the practice as "excellent because they clearly know the field, they work quickly and are very responsive to deadlines. They also give advice which is very much to the point."

Another client is impressed by the firm's technical knowledge and explains that "they are extremely good at combining knowledge of legislation and applying it to life sciences. They are extremely reasonable in their approach and they have very good business understanding."

Work highlights Assisted Sinensis with a transaction involving the sale of the pharmaceutical group to Eurofins.  

Significant clients Sanquin, Mucosis, Lead Pharma, Keygene, Milabs.

Notable practitioners  

Carine van den Brink focuses on commercial and contentious issues and is particularly active in transactions, where sources note she has a "constructive attitude, working towards a successful deal, but also knows when to persist in the position of her clients." Numerous interviewees reference her medical background which is "an obvious advantage for her clients and the dynamics of any life science deal" according to sources. One client adds: "We don't need to explain the jargon to her. She is very smart, finds very good solutions and knows what is important for the future."

Erik Vollebregt is known for his specialism in regulatory work, which covers medical technology, devices and products as well as biotechnology. Clients confirm his strong capabilities, with one saying "he stands out to me. Whenever I work with lawyers he has been the best, with a solid scientific background. He has the perfect combination of skills and experience."

^ Return to Top

Band 2

第二等

From the Chambers Europe guide

Basic facts about the department
- 3 partners
- 4 other qualified lawyers

What the team is known for Boutique firm with a particular focus on European and Dutch pharmaceutical regulatory law. Advises clients on a range of issues including veterinary and medical devices, product safety and certification and compliance. Also assists clients, which include research hospitals, large pharmaceutical and food companies, with discussions with regulators and authorities.

Strengths Sources report that the team is "very nice to deal with and passionate about what they do. They have always delivered work on time, which is thorough and offers insight into difficult issues."

A client is impressed by the firm's "very high service rating" which is characterised by its availability and support and says: "They are always there, they are very accessible, and always come back to me within the hour."

Work highlights Advised on claims from patients following a worldwide voluntary recall of DePuy Orthopaedics' ASR hip implants.

Assisted DMB with a range of regulatory issues under EU and Dutch law relating to the manufacture, distribution, sale and supply of special unauthorized medicinal products.

Significant clients Novartis, Roche, Tiofarma, Vertex, Novo Nordisk.

Notable practitioners  

Koosje van Lessen Kloeke advises on life sciences regulation at a Dutch and EU level including contentious proceedings before regulatory authorities and judicial review proceedings. Sources say "she has close relationships with associations and regulators in the Netherlands and knows the Dutch market inside out." Various other interviewees describe her as "a rock star in regulatory litigation" and say "you want to hire a lawyer just for the fun of working with her. She has an extreme sense of the political environment and sensitivities of the work she does."

^ Return to Top

Band 3

第三等

From the Chambers Europe guide

Basic facts about the department
- 3 partners
- 6 other qualified lawyers

What the team is known for Best known for its strength in transactional matters in the life sciences sector, including M&A, IPOs and financing work related to regulated entities in the pharmaceutical, health and food industries. Also advises clients on contentious issues, including regulatory and compliance matters, investigations and litigation and is integrated with the firm's respected patent litigation team.

Strengths One client reports that the firm "offers a really top notch service. They are very easy to work with and really proactive so I don't have to worry about them."

Work highlights Defended Biomet in its dispute with German company, Heraeus Medical, regarding an alleged misappropriation of trade secrets relating to bone cement products by Biomet. 

Represented Teva in its contested USD40 billion bid to takeover Mylan.

Significant clients Ferring, AIMM, Biogen, AbbVie.

Notable practitioners  

The key partners for life sciences clients are Tobias Cohen Jehoram, Gertjan Kuipers and Jan Pieter Hustinx.

^ Return to Top

Band 1

HOYNG ROKH MONEGIER

From the Chambers Europe guide

Carla Schoonderbeek leads the regulatory practice at the firm and is widely reputed as a leading expert in the life sciences regulatory arena throughout Europe. Sources confirm that "there is little doubt she is one of the best in the regulatory field," with another describing her a "a phenomenon." Acting at both the domestic and EU levels, she frequently represents innovators in the pharma and biotech fields on a diverse range of product and trial issues, compliance and enforcement litigation.

^ Return to Top

Band 2

Axon Lawyers

From the Chambers Europe guide

Carine van den Brink focuses on commercial and contentious issues and is particularly active in transactions, where sources note she has a "constructive attitude, working towards a successful deal, but also knows when to persist in the position of her clients." Numerous interviewees reference her medical background which is "an obvious advantage for her clients and the dynamics of any life science deal" according to sources. One client adds: "We don't need to explain the jargon to her. She is very smart, finds very good solutions and knows what is important for the future."

^ Return to Top

Band 2

Leijnse Artz

From the Chambers Europe guide

Koosje van Lessen Kloeke advises on life sciences regulation at a Dutch and EU level including contentious proceedings before regulatory authorities and judicial review proceedings. Sources say "she has close relationships with associations and regulators in the Netherlands and knows the Dutch market inside out." Various other interviewees describe her as "a rock star in regulatory litigation" and say "you want to hire a lawyer just for the fun of working with her. She has an extreme sense of the political environment and sensitivities of the work she does."

^ Return to Top

Band 2

Axon Lawyers

From the Chambers Europe guide

Erik Vollebregt is known for his specialism in regulatory work, which covers medical technology, devices and products as well as biotechnology. Clients confirm his strong capabilities, with one saying "he stands out to me. Whenever I work with lawyers he has been the best, with a solid scientific background. He has the perfect combination of skills and experience."

^ Return to Top

Band 3

Allen & Overy LLP

From the Chambers Europe guide

Christiaan de Brauw of Allen & Overy LLP offers significant experience of corporate law, IPOs within life sciences and maintains an active profile advising on transactions within the sector. His recent work has included representing several pharmaceutical companies in M&A activity.

^ Return to Top

Band 3

Hogan Lovells International LLP

From the Chambers Europe guide

Hein van den Bos is praised by clients for his "really helpful and understanding approach to internal issues." He leads the regulatory angle of the practice and advises on a range of compliance issues including rules governing the advertising of pharmaceutical products, exclusivity rights for new treatments and pricing negotiations relating to medicinal products.

^ Return to Top

Band 3

Macro & Versteeg advocaten

From the Chambers Europe guide

Arnold Versteeg of Macro & Versteeg advocaten is an experienced regulatory lawyer within both the life science and healthcare sectors, with a particular focus on the regulation of medicinal products. He represents clients in both contentious and advisory matters and sources confirm "his quality of work is top notch."

^ Return to Top